Drug Discovery Solutions
-
CRISPR/Cas9 And Cas9 Variants
9/30/2025
A quick overview of this industry-changing technology as well as the newer Cas9 variants that expand its use.
-
PUREplatform PUREcoli, A Pure Microbial Strain For Protein Production
3/17/2023
PUREplatform offers a platform, a premium strain, and cutting-edge screening, which together yield optimal protein expression that is uniquely tailored to each project.
-
SUREtechnology Platform™
8/4/2023
Explore how an advanced Cell Line Development (CLD) platform for new biologics can enable CHO-based cell line development; ensure premium, stable, and high-yield results; overcome common expression bottlenecks; and provide robust verification, genomic characterization, and monoclonality assessment services.
-
Discover Our iPSC Differentiated Cell Services
9/30/2025
iPSC-differentiated cell lines combine scalability and biorelevance, enabling precise disease modeling, drug screening, and regenerative research with customizable lineage-specific differentiation options.
-
Analytical Labs Particle Analysis
Particulate in a drug product represents a huge risk not only to patient safety – but also to a drug company’s reputation and bottom line. As concern about particulate rises, partnering with a particle analysis team enables customers to gain an intimate understanding of particle sources related to packaging and delivery systems.
-
SUREmAb — Monoclonal Antibody Development, The Way It's Meant To Be
8/4/2023
Leverage robust development strategies and enable an optimized process for mAb development and manufacturing, efficiency and speed with exceptional quality, and high titers with lower-cost workflows for maximum ROI.
-
Cell Line Development
2/17/2022
Our experience developing mammalian and microbial cell lines and our analytical capabilities enable us to identify and select clones that meet your product’s specific parameters and characteristics.
-
iPSC Generation Services
9/30/2025
iPSC generation is a complex process of reprogramming adult somatic cells into a pluripotent, embryonic stem cell-like stage.
-
Scientific Insights Lab Simplifying The Journey From Molecule To Market
Drug development programs should aid customers in the successful mitigation of technical and regulatory risks to ensure drug products move swiftly through the regulatory approval process and into commercialization. Get service and support to help pharmaceutical and biopharmaceutical manufacturers Simplify the Journey™ from molecule to market.
-
CHEF1™ Expression Technology
2/17/2022
The platform accelerates development of cell lines for cGMP production by using robust procedures and reliable raw materials, including chemically defined media, adapted Chinese hamster ovary (CHO) cells, and proprietary expression plasmids, to rapidly produce high levels of recombinant protein.